MCK · 8-K · 20260805PR000232

Liquidity and Debt Position

MCKESSON CORP · 2026-08-05 · Importance 77 · Surprise 82 · From source text

Cash and cash equivalents increased to $5.164 billion at June 30, 2026 from $3.975 billion at March 31, 2026. Long-term debt rose to $8.432 billion from $5.259 billion, and current debt was $1.297 billion, reflecting $3.215 billion of long-term debt issuance during the quarter. The company used $220 million of operating cash flow and invested $152 million in capital expenditures, producing negative free cash flow of $372 million.

Key facts

On June 9, 2026, McKesson established a secured Term Loan B facility of $2.25 billion in support of the planned separation of Medical-Surgical Solutions segment. source
Long-term debt at June 30, 2026: $8,432 million (compared to $5,259 million at March 31, 2026). source
Redeemable noncontrolling interests at June 30, 2026: $2,563 million (up from $943 million at March 31, 2026). source
Net cash provided by financing activities for the three months ended June 30, 2026: $1,632 million (versus $1,176 million prior year). source
Interest expense for the quarter: $77 million, increased 57% versus prior year. source
Proceeds from issuances of long-term debt in the quarter: $3,215 million. source
Receivables, net at June 30, 2026: $30,316 million. source
Inventories, net at June 30, 2026: $26,259 million. source

Impact estimates

metric	direction	stage	expected	basis
liability	negative	committed	—	On June 9, 2026, McKesson established a secured Term Loan B facility of $2.25 billion in support of the planned separation of…
liability	negative	realized	—	Long-term debt at June 30, 2026: $8,432 million (compared to $5,259 million at March 31, 2026).
liability	negative	realized	—	Redeemable noncontrolling interests at June 30, 2026: $2,563 million (up from $943 million at March 31, 2026).
cash	positive	realized	—	Net cash provided by financing activities for the three months ended June 30, 2026: $1,632 million (versus $1,176 million prior year).